Screenin3d

Revolutionizing drug discovery with predictive 3D human disease models

placeCambridge, Massachusetts, United States calendar_todayFounded 2018 groups4 employees language screenin3d.com

Social engagement

Social engagement: 993 social following, 5 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Tricapital.

Investor typeCountShare
Venture capital120%
Angel & family office120%
Other / undisclosed360%

Recent activity

29 May 2026
Event
webinar on drug efficacy tests in 3D using translational cancer models
19 Mar 2026
Event
Webinar on UpScale3D microfluidic technology for scalable, pharmacodynamic and drug combination testing
13 Oct 2025
Event
ELRIG Drug Discovery
Coming soon